<p>美瑞医疗系统公司（NASDAQ:MMSI - 获取免费报告）在周五的交易中股价创下 52 周新低。该公司股价最低跌至 80.10 美元，最后交易价格为 85.65 美元，成交量为 711 股。该股票此前收盘价为 85.65 美元。</p>
<p>获取 <strong>美瑞医疗系统</strong> 的提醒：</p>
<h2>华尔街分析师预测增长</h2>
<p>多家股票研究分析师对 MMSI 股票发表了评论。Canaccord Genuity Group 在 5 月 21 日的研究报告中将美瑞医疗系统的目标价格设定为 112.00 美元，并给予该公司 “买入” 评级。Barrington Research 在 7 月 31 日的报告中重申了 “跑赢大盘” 评级，并对美瑞医疗系统的股票设定了 103.00 美元的价格目标。富国银行在 7 月 31 日的研究报告中将美瑞医疗系统的目标价格从 108.00 美元下调至 100.00 美元，并对该公司设定了 “增持” 评级。Raymond James Financial 在 7 月 31 日的研究报告中将美瑞医疗系统的价格目标从 108.00 美元下调至 102.00 美元，并对该公司设定了 “跑赢大盘” 评级。最后，Piper Sandler 在 7 月 31 日的研究报告中将美瑞医疗系统的价格目标从 110.00 美元下调至 105.00 美元，并对该股票设定了 “增持” 评级。两位分析师对该股票给予了持有评级，八位分析师给予了买入评级。根据 MarketBeat 的数据，美瑞医疗系统目前的平均评级为 “适度买入”，平均目标价格为 107.00 美元。</p>
<p><strong>查看我们关于美瑞医疗系统的最新股票报告</strong></p>
<h2>美瑞医疗系统的价格表现</h2>
<p>该公司的市值为 50.7 亿美元，市盈率为 43.42，市盈增长比率为 2.73，贝塔值为 0.66。该股票的 50 日简单移动平均线为 90.55 美元，200 日简单移动平均线为 96.70 美元。该公司的流动比率为 4.09，速动比率为 2.66，债务股本比率为 0.49。</p>
<p>美瑞医疗系统（NASDAQ:MMSI - 获取免费报告）最近在 7 月 30 日发布了季度收益数据。这家医疗仪器供应商报告本季度每股收益（EPS）为 1.01 美元，超出市场共识预期的 0.85 美元，超出幅度为 0.16 美元。美瑞医疗系统的股本回报率为 15.07%，净利润率为 8.31%。该公司本季度的收入为 3.8246 亿美元，而市场共识预期为 3.7247 亿美元。在去年同期，该公司每股收益为 0.92 美元。与去年同期相比，该公司的季度收入增长了 13.2%。分析师平均预测美瑞医疗系统将在本财年发布 3.37 美元的每股收益。</p>
<h2>内部活动</h2>
<p>在其他消息中，董事 F. Ann Millner 在 5 月 15 日的交易中出售了 21,250 股美瑞医疗系统的股票。该股票以平均价格 96.47 美元出售，总价值为 2,049,987.50 美元。交易后，该董事直接持有 34,543 股公司股票，价值为 3,332,363.21 美元。此次交易使其持股减少了 38.09%。该交易已在向 SEC 提交的文件中披露，文件可在此链接查看。此外，董事 Michael R. Mcdonnell 在 6 月 2 日的交易中出售了 1,750 股该股票。该股票以平均价格 94.51 美元出售，总交易额为 165,392.50 美元。交易完成后，该董事直接持有 6,395 股公司股票，价值为 604,391.45 美元。此次交易使其持股减少了 21.49%。该销售的披露信息可以在这里找到。在过去 90 天内，内部人士共出售了 85,596 股公司股票，价值为 8,171,433 美元。公司内部人士持有该股票的比例为 3.20%。</p>
<h2>机构投资者对美瑞医疗系统的看法</h2>
<p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。Maseco LLP 在第二季度收购了美瑞医疗系统的新股份，价值约为 28,000 美元。Opal Wealth Advisors LLC 在第一季度购买了美瑞医疗系统的新头寸，价值约为 31,000 美元。IFP Advisors Inc 在第一季度将其在美瑞医疗系统的股份增加了 1,435.0%。IFP Advisors Inc 现在拥有 307 股该医疗仪器供应商的股票，价值 32,000 美元，此前在该期间内又收购了 287 股。MassMutual Private Wealth &amp; Trust FSB 在第二季度将其在美瑞医疗系统的持股增加了 55.6%。MassMutual Private Wealth &amp; Trust FSB 现在拥有 375 股该医疗仪器供应商的股票，价值 35,000 美元，此前在上个季度又购买了 134 股。最后，西北互助财富管理公司在第一季度将其在美瑞医疗系统的持股增加了 119.8%。西北互助财富管理公司现在拥有 367 股该医疗仪器供应商的股票，价值 39,000 美元，此前在上个季度又购买了 200 股。目前 99.66% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>美瑞医疗系统公司简介</h2>
<p>（获取免费报告）</p>
<p>Merit 医疗系统公司设计、开发、制造和销售一次性医疗产品，适用于美国及国际上的介入、诊断和治疗程序。该公司分为两个部门：心血管和内窥镜。公司提供微穿刺套件、血管造影针、鞘管、导丝和安全产品；外周介入，包括血管造影、引流、输送系统和栓塞治疗产品；脊柱产品，如椎体成形术、射频消融和骨活检系统；肿瘤产品；以及心脏介入产品，如通道、血管造影、电生理和心律管理、液体管理、血流动力学监测、止血和治疗各种心脏疾病的介入。</p>
<h2>另见</h2>
<ul>
<li>五只我们认为比 Merit 医疗系统更好的股票</li>
<li>3 只前景良好的金融科技股票</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>如何利用高贝塔股票最大化投资利润</li>
<li>亚马逊对 IonQ 进行股权投资——是否有上涨潜力？</li>
<li>最大股票亏损者 - 今日最大百分比下跌者</li>
<li>华尔街已将英特尔视为死去——但你不应该这样做的原因</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Merit 医疗系统吗？</h2>
<p>在你考虑 Merit 医疗系统之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Merit 医疗系统并不在名单上。</p>
<p>虽然 Merit 医疗系统目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Merit医疗系统

<p>Merit 医疗系统（NASDAQ:MMSI）股票创下 52 周新低，报$80.10，收盘价为$85.65，交易量为 711 股。分析师的评级不一，目标价格范围在$100 到$112 之间。该公司报告每股收益为$1.01，超出预期，营收同比增长 13.2%。内部交易活动中，董事们进行了大量出售。机构投资者也积极参与，增持了该公司的新股份</p>

<p>Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) shares reached a new 52-week low during trading on Friday . The company traded as low as $80.10 and last traded at $85.65, with a volume of 711 shares changing hands. The stock had previously closed at $85.65.</p>
<div class="lb-trans"><p>美瑞医疗系统公司（NASDAQ:MMSI - 获取免费报告）在周五的交易中股价创下 52 周新低。该公司股价最低跌至 80.10 美元，最后交易价格为 85.65 美元，成交量为 711 股。该股票此前收盘价为 85.65 美元。</p>
</div><p>Get <strong>Merit Medical Systems</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>美瑞医疗系统</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of equities research analysts have commented on MMSI shares. Canaccord Genuity Group set a $112.00 target price on Merit Medical Systems and gave the company a &#34;buy&#34; rating in a research report on Wednesday, May 21st. Barrington Research restated an &#34;outperform&#34; rating and issued a $103.00 price objective on shares of Merit Medical Systems in a report on Thursday, July 31st. Wells Fargo &amp; Company lowered their target price on shares of Merit Medical Systems from $108.00 to $100.00 and set an &#34;overweight&#34; rating for the company in a research note on Thursday, July 31st. Raymond James Financial dropped their price target on shares of Merit Medical Systems from $108.00 to $102.00 and set an &#34;outperform&#34; rating for the company in a research report on Thursday, July 31st. Finally, Piper Sandler reduced their price target on shares of Merit Medical Systems from $110.00 to $105.00 and set an &#34;overweight&#34; rating on the stock in a research note on Thursday, July 31st. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Merit Medical Systems currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $107.00.</p>
<div class="lb-trans"><p>多家股票研究分析师对 MMSI 股票发表了评论。Canaccord Genuity Group 在 5 月 21 日的研究报告中将美瑞医疗系统的目标价格设定为 112.00 美元，并给予该公司 “买入” 评级。Barrington Research 在 7 月 31 日的报告中重申了 “跑赢大盘” 评级，并对美瑞医疗系统的股票设定了 103.00 美元的价格目标。富国银行在 7 月 31 日的研究报告中将美瑞医疗系统的目标价格从 108.00 美元下调至 100.00 美元，并对该公司设定了 “增持” 评级。Raymond James Financial 在 7 月 31 日的研究报告中将美瑞医疗系统的价格目标从 108.00 美元下调至 102.00 美元，并对该公司设定了 “跑赢大盘” 评级。最后，Piper Sandler 在 7 月 31 日的研究报告中将美瑞医疗系统的价格目标从 110.00 美元下调至 105.00 美元，并对该股票设定了 “增持” 评级。两位分析师对该股票给予了持有评级，八位分析师给予了买入评级。根据 MarketBeat 的数据，美瑞医疗系统目前的平均评级为 “适度买入”，平均目标价格为 107.00 美元。</p>
</div><p><strong>View Our Latest Stock Report on Merit Medical Systems</strong></p>
<div class="lb-trans"><p><strong>查看我们关于美瑞医疗系统的最新股票报告</strong></p>
</div><h2>Merit Medical Systems Price Performance</h2>
<div class="lb-trans"><h2>美瑞医疗系统的价格表现</h2>
</div><p>The company has a market cap of $5.07 billion, a PE ratio of 43.42, a price-to-earnings-growth ratio of 2.73 and a beta of 0.66. The stock has a fifty day simple moving average of $90.55 and a two-hundred day simple moving average of $96.70. The company has a current ratio of 4.09, a quick ratio of 2.66 and a debt-to-equity ratio of 0.49.</p>
<div class="lb-trans"><p>该公司的市值为 50.7 亿美元，市盈率为 43.42，市盈增长比率为 2.73，贝塔值为 0.66。该股票的 50 日简单移动平均线为 90.55 美元，200 日简单移动平均线为 96.70 美元。该公司的流动比率为 4.09，速动比率为 2.66，债务股本比率为 0.49。</p>
</div><p>Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The medical instruments supplier reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.16. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%. The firm had revenue of $382.46 million during the quarter, compared to the consensus estimate of $372.47 million. During the same period in the previous year, the firm posted $0.92 EPS. The company's quarterly revenue was up 13.2% compared to the same quarter last year. On average, equities analysts predict that Merit Medical Systems, Inc. will post 3.37 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>美瑞医疗系统（NASDAQ:MMSI - 获取免费报告）最近在 7 月 30 日发布了季度收益数据。这家医疗仪器供应商报告本季度每股收益（EPS）为 1.01 美元，超出市场共识预期的 0.85 美元，超出幅度为 0.16 美元。美瑞医疗系统的股本回报率为 15.07%，净利润率为 8.31%。该公司本季度的收入为 3.8246 亿美元，而市场共识预期为 3.7247 亿美元。在去年同期，该公司每股收益为 0.92 美元。与去年同期相比，该公司的季度收入增长了 13.2%。分析师平均预测美瑞医疗系统将在本财年发布 3.37 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other news, Director F. Ann Millner sold 21,250 shares of Merit Medical Systems stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $96.47, for a total value of $2,049,987.50. Following the transaction, the director directly owned 34,543 shares of the company's stock, valued at $3,332,363.21. The trade was a 38.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Michael R. Mcdonnell sold 1,750 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $94.51, for a total transaction of $165,392.50. Following the completion of the sale, the director directly owned 6,395 shares of the company's stock, valued at $604,391.45. The trade was a 21.49% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 85,596 shares of company stock valued at $8,171,433 in the last ninety days. 3.20% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，董事 F. Ann Millner 在 5 月 15 日的交易中出售了 21,250 股美瑞医疗系统的股票。该股票以平均价格 96.47 美元出售，总价值为 2,049,987.50 美元。交易后，该董事直接持有 34,543 股公司股票，价值为 3,332,363.21 美元。此次交易使其持股减少了 38.09%。该交易已在向 SEC 提交的文件中披露，文件可在此链接查看。此外，董事 Michael R. Mcdonnell 在 6 月 2 日的交易中出售了 1,750 股该股票。该股票以平均价格 94.51 美元出售，总交易额为 165,392.50 美元。交易完成后，该董事直接持有 6,395 股公司股票，价值为 604,391.45 美元。此次交易使其持股减少了 21.49%。该销售的披露信息可以在这里找到。在过去 90 天内，内部人士共出售了 85,596 股公司股票，价值为 8,171,433 美元。公司内部人士持有该股票的比例为 3.20%。</p>
</div><h2>Institutional Investors Weigh In On Merit Medical Systems</h2>
<div class="lb-trans"><h2>机构投资者对美瑞医疗系统的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the business. Maseco LLP acquired a new stake in shares of Merit Medical Systems during the 2nd quarter valued at approximately $28,000. Opal Wealth Advisors LLC bought a new position in Merit Medical Systems in the first quarter worth about $31,000. IFP Advisors Inc boosted its stake in Merit Medical Systems by 1,435.0% in the first quarter. IFP Advisors Inc now owns 307 shares of the medical instruments supplier's stock valued at $32,000 after acquiring an additional 287 shares during the period. MassMutual Private Wealth &amp; Trust FSB grew its holdings in shares of Merit Medical Systems by 55.6% during the second quarter. MassMutual Private Wealth &amp; Trust FSB now owns 375 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 134 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Merit Medical Systems by 119.8% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 200 shares during the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近买入和卖出了该公司的股票。Maseco LLP 在第二季度收购了美瑞医疗系统的新股份，价值约为 28,000 美元。Opal Wealth Advisors LLC 在第一季度购买了美瑞医疗系统的新头寸，价值约为 31,000 美元。IFP Advisors Inc 在第一季度将其在美瑞医疗系统的股份增加了 1,435.0%。IFP Advisors Inc 现在拥有 307 股该医疗仪器供应商的股票，价值 32,000 美元，此前在该期间内又收购了 287 股。MassMutual Private Wealth &amp; Trust FSB 在第二季度将其在美瑞医疗系统的持股增加了 55.6%。MassMutual Private Wealth &amp; Trust FSB 现在拥有 375 股该医疗仪器供应商的股票，价值 35,000 美元，此前在上个季度又购买了 134 股。最后，西北互助财富管理公司在第一季度将其在美瑞医疗系统的持股增加了 119.8%。西北互助财富管理公司现在拥有 367 股该医疗仪器供应商的股票，价值 39,000 美元，此前在上个季度又购买了 200 股。目前 99.66% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Merit Medical Systems Company Profile</h2>
<div class="lb-trans"><h2>美瑞医疗系统公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.</p>
<div class="lb-trans"><p>Merit 医疗系统公司设计、开发、制造和销售一次性医疗产品，适用于美国及国际上的介入、诊断和治疗程序。该公司分为两个部门：心血管和内窥镜。公司提供微穿刺套件、血管造影针、鞘管、导丝和安全产品；外周介入，包括血管造影、引流、输送系统和栓塞治疗产品；脊柱产品，如椎体成形术、射频消融和骨活检系统；肿瘤产品；以及心脏介入产品，如通道、血管造影、电生理和心律管理、液体管理、血流动力学监测、止血和治疗各种心脏疾病的介入。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Merit Medical Systems</li>
<li>3 Fintech Stocks With Good 2021 Prospects</li>
<li>DraftKings Posts Record Quarter, Eyes Profitability</li>
<li>How to Use High Beta Stocks to Maximize Your Investing Profits</li>
<li>Amazon Takes an Equity Stake in IonQ—Any Upside Potential?</li>
<li>Biggest Stock Losers - Today’s Biggest Percentage Decliners</li>
<li>Wall Street Has Left Intel for Dead—Here's Why You Shouldn’t</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Merit 医疗系统更好的股票</li>
<li>3 只前景良好的金融科技股票</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>如何利用高贝塔股票最大化投资利润</li>
<li>亚马逊对 IonQ 进行股权投资——是否有上涨潜力？</li>
<li>最大股票亏损者 - 今日最大百分比下跌者</li>
<li>华尔街已将英特尔视为死去——但你不应该这样做的原因</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Merit Medical Systems Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Merit 医疗系统吗？</h2>
</div><p>Before you consider Merit Medical Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Merit 医疗系统之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merit Medical Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Merit 医疗系统并不在名单上。</p>
</div><p>While Merit Medical Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Merit 医疗系统目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Merit 医疗系统（NASDAQ:MMSI）创下新的 52 周低点 - 以下是发生的情况